Pacific Biosciences of California, Inc.

NasdaqGS:PACB 주식 보고서

시가총액: US$476.9m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Pacific Biosciences of California 관리

관리 기준 확인 2/4

Pacific Biosciences of California's CEO는 Christian O. Henry, Sep2020 에 임명되었습니다 의 임기는 3.92 년입니다. 총 연간 보상은 $ 8.05M, 8.6% 로 구성됩니다. 8.6% 급여 및 91.4% 보너스(회사 주식 및 옵션 포함). 는 $ 446.84K 가치에 해당하는 회사 주식의 0.11% 직접 소유합니다. 446.84K. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 11.5 년입니다.

주요 정보

Christian O. Henry

최고 경영자

US$8.0m

총 보상

CEO 급여 비율8.6%
CEO 임기4yrs
CEO 소유권0.1%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간11.6yrs

최근 관리 업데이트

Recent updates

Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely

Sep 20
Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely

Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing

Aug 21

Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper

Jul 02
Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper

We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt

Jun 08
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt

Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas

Jun 03

These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat

Apr 25
These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat

It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks

Apr 16
It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks

Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership

Mar 19

Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth

Feb 08

With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For

Feb 01
With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For

What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S

Dec 18
What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S

Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?

Nov 13
Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?

The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%

Aug 28
The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%

Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?

Jul 31
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?

Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Jul 06
Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt

May 25
Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt

Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Mar 29
Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?

Feb 26
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?

CEO 보상 분석

Christian O. Henry 의 보수는 Pacific Biosciences of California 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$400m

Mar 31 2024n/an/a

-US$297m

Dec 31 2023US$8mUS$695k

-US$307m

Sep 30 2023n/an/a

-US$309m

Jun 30 2023n/an/a

-US$319m

Mar 31 2023n/an/a

-US$321m

Dec 31 2022US$7mUS$667k

-US$314m

Sep 30 2022n/an/a

-US$299m

Jun 30 2022n/an/a

-US$206m

Mar 31 2022n/an/a

-US$175m

Dec 31 2021US$3mUS$650k

-US$181m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$59m

Dec 31 2020US$13mUS$195k

US$29m

Sep 30 2020n/an/a

-US$46m

Jun 30 2020n/an/a

-US$51m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$100kn/a

-US$84m

Sep 30 2019n/an/a

-US$115m

Jun 30 2019n/an/a

-US$111m

Mar 31 2019n/an/a

-US$109m

Dec 31 2018US$88kn/a

-US$103m

보상 대 시장: Christian O. 의 총 보상 ($USD 8.05M )은 US 시장( $USD 2.41M ).

보상과 수익: 회사가 수익성이 없는 동안 Christian O. 의 보상이 증가했습니다.


CEO

Christian O. Henry (56 yo)

4yrs

테뉴어

US$8,046,575

보상

Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...


리더십 팀

이름위치테뉴어보상소유권
Christian O. Henry
President4yrsUS$8.05m0.14%
$ 679.9k
Susan Kim
Chief Financial Officer4yrsUS$2.52m0.036%
$ 170.4k
Mark Van Oene
Chief Operating Officer3.7yrsUS$4.60m0.12%
$ 553.6k
Jeff Eidel
Chief Commercial Officer2.1yrsUS$2.53m0.050%
$ 236.7k
Stephen Turner
Co-Founder24.2yrsUS$466.76k데이터 없음
Michele Farmer
VP & Chief Accounting Officer3.3yrs데이터 없음0.013%
$ 63.4k
Brett Atkins
General Counsel & Corporate Secretaryno data데이터 없음데이터 없음
Natalie Welch
Chief People Officerno data데이터 없음데이터 없음

3.8yrs

평균 재임 기간

49.5yo

평균 연령

경험이 풍부한 관리: PACB 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Christian O. Henry
President6.2yrsUS$8.05m0.14%
$ 679.9k
William Ericson
Independent Director20.7yrsUS$259.00k0.0069%
$ 32.9k
Lucy Shapiro
Independent Director12yrsUS$255.00k0%
$ 0
John Milligan
Independent Chairman11.2yrsUS$297.00k0.040%
$ 192.5k
Harry Gray
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Joseph Bonventre
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Randall Livingston
Independent Director15.7yrsUS$265.00k0%
$ 0
Harold Craighead
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Roger Kornberg
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Watt Webb
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Kenneth Johnson
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Jay Shendure
Chairman of Scientific Advisory Board1.8yrs데이터 없음데이터 없음

11.6yrs

평균 재임 기간

70yo

평균 연령

경험이 풍부한 이사회: PACB 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 11.5 년).